
|Articles|January 25, 2008
Once-daily amoxicillin approved
Moxatag is the name of a new once-daily amoxicillin product for pharyngitis and tonsillitis following strep throat
Advertisement
MiddleBrook Pharmaceuticals' Moxatag (amoxicillin extended-release) Tablets 775 mg have been approved to treat adults and children 12 and older with pharyngitis and/or tonsillitis secondary to strep throat. The Germantown, Md., firm claims that its product is the first once-daily amoxicillin product approved in this country. Its convenient dosing should ensure better drug compliance.
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
4
Pharmacists Want Prescribing Authority With Proper Training, Support
5






























